acetylcysteine has been researched along with Thromboembolism in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, C; Denis, CV; Diamond, SL; Gakuba, C; Gauberti, M; Herbig, BA; Lenting, PJ; Martinez de Lizarrondo, S; Repessé, Y; Touzé, E; Vivien, D | 1 |
Genest, M; Pochmalicki, G | 1 |
Caggiano, M; Gogliettino, A; Mannelli, R; Ortolani, O; Tufano, R | 1 |
1 review(s) available for acetylcysteine and Thromboembolism
Article | Year |
---|---|
[Diagnostic and therapeutic progress. Venous thromboembolism, cardiac insufficiency and radio contrast agents].
Topics: Acetylcysteine; Acute Disease; Adrenergic beta-Antagonists; Anticoagulants; Counterpulsation; Diastole; Diuretics; Echocardiography; Electric Countershock; Fibrin Fibrinogen Degradation Products; Fluid Therapy; Heart Failure; Hemofiltration; Heparin; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Oxygen Inhalation Therapy; Pulmonary Edema; Thromboembolism; Tissue Plasminogen Activator; Treatment Outcome; Vasodilator Agents; Venous Thrombosis | 2004 |
1 trial(s) available for acetylcysteine and Thromboembolism
Article | Year |
---|---|
Protection from ischemia-reperfusion damage in patients with stroke: the role of rutin and GSH.
Topics: Acetylcysteine; Aged; Analysis of Variance; Antithrombin III; Cell Aggregation; Cerebrovascular Disorders; Cytidine Diphosphate Choline; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Fibrinogen; Fibrinopeptide A; Glutathione; Humans; Infusions, Intravenous; Leukocytes; Male; Middle Aged; Nootropic Agents; Reperfusion Injury; Rutin; Thromboembolism | 1995 |
1 other study(ies) available for acetylcysteine and Thromboembolism
Article | Year |
---|---|
Potent Thrombolytic Effect of
Topics: Acetylcysteine; Animals; Blood Platelets; Chlorides; Disease Models, Animal; Ferric Compounds; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Mice; Platelet Aggregation; Ristocetin; Thromboembolism; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2017 |